Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · InspireMD, Inc. (NSPR)

InspireMD eliminates Chief Commercial Officer Shane Gleason's position, effective July 31, 2026

Neutral Impact 4 of 5 leadership Written later

InspireMD notified Chief Commercial Officer Shane Gleason on July 23, 2026 that his position has been eliminated. His last day of employment is July 31, 2026. The filing does not describe a successor or the reasons for the elimination, so shareholders have limited detail on how the change affects commercial operations.

Key points

  • Position of Chief Commercial Officer Shane Gleason eliminated; notice given July 23, 2026
  • Last day of employment for Gleason: July 31, 2026
  • Filing contains no successor appointment or reason for the elimination

The filing

CompanyInspireMD, Inc. (NSPR)
Form8-K, current report
Filed with the SECJul 29, 2026, 5:00 PM ET
Accession number0001493152-26-035220

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 29, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.